小直径二叶式主动脉病变的手术修复:临床与机构因素
该研究基于两个大型心血管注册库,纳入1996至2015年间18家机构的2861例二叶式主动脉瓣患者,分析影响升主动脉干预(AAI)决策的因素。结果显示,接受AAI的患者主动脉直径中位数在不同机构间差异显著(39-52 mm),38%的患者在直径<45 mm时即接受干预。临床与机构因素影响AAI时机,导致各机构间干预时主动脉直径存在显著变异。
要点
- 二叶式主动脉瓣患者接受升主动脉干预时,主动脉直径在不同机构间差异大(中位数39-52 mm)。
- 38%接受升主动脉干预的患者主动脉直径<45 mm。
- 临床与机构因素影响升主动脉干预时机,导致实践变异。
核心结论
- 临床与机构因素影响二叶式主动脉瓣患者升主动脉干预的时机,并导致各机构间干预时主动脉直径存在显著变异。
- 超过三分之一的二叶式主动脉瓣患者在接受升主动脉干预时主动脉直径<45 mm。
研究设计与样本
- 研究基于两个大型心血管注册库,纳入2861例已知主动脉直径和手术状态的二叶式主动脉瓣患者,来自18家机构,时间跨度为1996年至2015年。
- 采用多因素logistic回归分析,按患者特征、手术指征和机构分层,分析单纯主动脉瓣置换(AVR)或AVR+升主动脉干预(AAI)的预测因素。
主要发现
- 接受AVR+AAI的患者主动脉直径中位数在不同机构间差异广泛(39-52 mm)。
- 38%接受AVR+AAI的患者主动脉直径<45 mm。
- 与未手术管理的患者相比,在直径<45 mm时接受AAI的患者更年轻(54 ± 13 vs 61 ± 15岁;P < .001),且主动脉瓣狭窄(53% vs 28%;P < .001)和反流(52% vs 18%;P < .001)更常见。
临床怎么用
- 临床实践中应认识到二叶式主动脉瓣患者升主动脉干预时机存在显著机构间变异,需结合患者特征和机构经验个体化决策。
- 对于直径<45 mm的二叶式主动脉瓣患者,需谨慎评估早期干预的风险获益比,等待长期结局数据。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Bicuspid aortic valve is a common risk factor for thoracic aortic aneurysm and dissection. Guidelines for elective ascending aortic intervention (AAI) in bicuspid aortic valve are derived from limited evidence, and the extent of practice variation due to patient and provider characteristics is unknown. Using data from 2 large cardiovascular registries, we investigated factors that influence decisions for AAI. METHODS: All bicuspid aortic valve cases with known aortic diameters and surgical status were included. We used multivariable logistic regression to profile predictors of isolated aortic valve replacement (AVR) or AVR+AAI, stratified by patient characteristics, surgical indications, and institution. RESULTS: We studied 2861 subjects at 18 institutions from 1996 to 2015. The median aortic diameter of patients who underwent AVR+AAI varied widely across institutions (39-52 mm). Aortic diameters were <45 mm in 38% of patients undergoing AVR+AAI. Patients who underwent AAI at <45 mm, compared with those managed nonoperatively, were younger (54 ± 13 vs 61 ± 15 years; P < .001) with more frequent aortic stenosis (53% vs 28%; P < .001) and regurgitation (52% vs 18%; P < .001). CONCLUSIONS: Clinical and institutional factors influence the timing of AAI and are associated with significant variability in ascending aortic diameter at AAI across institutions. More than one third of patients with a bicuspid aortic valve undergo AAI at aortic diameters <45 mm. Long-term outcomes of this subgroup of patients, who may manifest earlier and more severe disease, are needed to determine the risk-benefit ratio of routine aortic interventions at smaller diameters.
引用
- Nissen AP, Truong VTT, Alhafez BA, et al. Surgical repair of bicuspid aortopathy at small diameters: Clinical and institutional factors. J Thorac Cardiovasc Surg. 2019. PMID: 31543305. doi:10.1016/j.jtcvs.2019.06.103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。